Skip to main content

Making treatments available

Our international research programme means that life-changing treatments and developments for type 1 diabetes are in clinical trials around the world.

Hybrid closed loop technology

As new treatments become available, we want to make sure that they are delivered through the NHS to people with type 1 diabetes as quickly as possible.

Working with the NHS

To achieve this we provide evidence and patient input to the National Institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN). These are the two organisations that evaluate which medicines should be prescribed and paid for by the NHS, and provide guidelines to doctors about best treatment practices.

Representing people with type 1

As well as providing input for NICE and SIGN treatment reviews ourselves, we work with industry and researchers to ensure that they are producing appropriate evidence for these two bodies.

We also make sure that patients’ views are represented by asking people with type 1 diabetes to take part in reviews, and we help to keep people with type 1 up to date about the best and latest treatment options so that they can discuss them with their healthcare team.

Type 1 technology

We are a member of the Medical Technology Group (MTG), a coalition of patient groups, research charities and medical device manufacturers working to improve access to cost-effective medical technologies for everyone who needs them.

In 2018 we merged with diabetes technology advocacy group INPUT to address some of the problems which delay adoption of new treatments and technology through the NHS. We also work closely with partners like Diabetes UK to advocate for faster access to technology.

Treatment advocacy news

Read more
Nina Willer, who used hybrid closed loop technology through pregnancy, and her child.
Treatment research
7 November 2023

Hybrid closed loop technology set to be made available in England and Wales

The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.

Read more
A young guy with type 1 diabetes dealing with exam stress and taking an exam
Policy and advocacy
4 October 2023

Letter to Gillian Keegan about the use of mobile phones in schools

We’ve written a letter to Gillian Keegan MP, Secretary of State for Education, asking her to make exemptions to the Government’s policy on banning mobile phones in schools. We thought you might like to read it.

Read more
Illustration of the hybrid closed loop technology system, funded as part of treatment research for type 1 diabetes by JDRF.
Type 1 technology
21 August 2023

NICE’s latest consultation on hybrid closed loop

As part of its assessment of hybrid closed loop (HCL), the National Institute for Health and Care Excellence (NICE) has today published an additional consultation on its roll out.

Read more
A woman standing in a park using the Omnipod 5 system for type 1 diabetes
Type 1 technology
21 June 2023

Omnipod 5 becomes the latest hybrid closed loop system available in the UK

Insulet, the company who make Omnipod® products, has announced that their Omnipod® 5 hybrid closed loop (HCL) technology is now available in the UK.